Cancer Center A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Hemangiopericytoma"

Drug Intervention Trials that are Recruiting

Study Title
Principal Investigator Disease Category
SARC 009: A Phase II Trial of Dasatinib in Advanced Sarcomas Kristen N. Ganjoo
Hemangiopericytoma
Nerve Sheath Neoplasms
Rhabdomyosarcoma
Chordoma





The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: